Purdue Pharma Granted 60-Day Pause to Renegotiate Opioid Settlement

The pharmaceutical company aims to reach a new agreement with the Sackler family and other stakeholders following a Supreme Court decision.

U.S. Bankruptcy Judge Sean Lane approved a 60-day litigation freeze against Purdue Pharma's owners.
The Supreme Court ruled that Purdue's previous bankruptcy settlement cannot shield the Sacklers from opioid-related lawsuits.
Mediation efforts will involve state and local governments, individual plaintiffs, and other stakeholders.
If a new deal is not reached, litigation against the Sacklers could resume, potentially involving over 900 lawsuits.
Purdue and its creditors seek to recover billions allegedly transferred by the Sacklers to offshore accounts.